Enhabit (NYSE:EHAB) Issues FY 2024 Earnings Guidance

Enhabit (NYSE:EHAB) issued an update on its FY 2024 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 0.190-0.370 for the period, compared to the consensus earnings per share estimate of 0.270. The company issued revenue guidance of $1.1 billion-$1.1 billion, compared to the consensus revenue estimate of $1.1 billion.

Wall Street Analysts Forecast Growth

EHAB has been the topic of several analyst reports. SVB Leerink upgraded Enhabit from an underperform rating to a market perform rating and set a $8.50 price target on the stock in a report on Tuesday, May 14th. Jefferies Financial Group downgraded Enhabit from a buy rating to a hold rating and reduced their target price for the company from $14.00 to $8.75 in a research report on Thursday, May 9th. Bank of America lowered their price target on Enhabit from $9.00 to $8.00 and set an underperform rating for the company in a report on Thursday, June 27th. Finally, Leerink Partnrs upgraded shares of Enhabit from a strong sell rating to a hold rating in a report on Tuesday, May 14th. One analyst has rated the stock with a sell rating and seven have given a hold rating to the company. Based on data from MarketBeat, Enhabit currently has a consensus rating of Hold and an average target price of $9.79.

Enhabit Trading Up 3.1 %

EHAB traded up $0.30 during mid-day trading on Tuesday, hitting $9.90. 454,042 shares of the stock were exchanged, compared to its average volume of 559,921. The firm’s fifty day moving average is $9.23 and its two-hundred day moving average is $9.69. Enhabit has a 1-year low of $7.12 and a 1-year high of $14.22. The company has a market cap of $496.54 million, a PE ratio of -5.96, a PEG ratio of 1.58 and a beta of 1.85. The company has a current ratio of 1.50, a quick ratio of 1.50 and a debt-to-equity ratio of 0.75.

Enhabit (NYSE:EHAB) last announced its earnings results on Wednesday, May 8th. The company reported $0.07 earnings per share for the quarter, topping the consensus estimate of $0.05 by $0.02. The firm had revenue of $262.40 million for the quarter, compared to the consensus estimate of $268.25 million. Enhabit had a negative net margin of 7.95% and a positive return on equity of 1.43%. Equities analysts forecast that Enhabit will post 0.24 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, Director Jeffrey Bolton bought 10,000 shares of the business’s stock in a transaction that occurred on Friday, May 17th. The shares were purchased at an average cost of $8.33 per share, for a total transaction of $83,300.00. Following the completion of the purchase, the director now owns 52,299 shares of the company’s stock, valued at $435,650.67. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Insiders purchased 22,000 shares of company stock valued at $183,700 in the last three months. 1.90% of the stock is owned by corporate insiders.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.